Your version of Internet Explorer is not up to date. Please upgrade your browser to view GXP Consulting Switzerland correctly or use Chrome, Firefox or Safari.You can update your browser directly on the Microsoft website.

icon-chrome icon-firefox icon-explorer icon-safari

Votre version d'Internet Explorer n'est plus supportée. Pour visiter GXP Consulting Switzerland, veuillez mettre votre logiciel Internet Explorer à jour ou utiliser Chrome, Firefox ou Safari.Il est possible de trouver la dernière version d'Internet Explorer sur le site Microsoft.

icon-chrome icon-firefox icon-explorer icon-safari

17 February, 2026

Opening a New Chapter at Biopôle Lausanne

 

Supporting Life Sciences Across the Full GxP Lifecycle

 

For over ten years, we have partnered with pharmaceutical, biotech and medtech companies across the full GxP lifecycle — from early development to commercial operations. Our mission has always been to help organizations navigate complexity, accelerate transformation and maintain the highest standards of quality and compliance in an increasingly demanding and fast-evolving environment.

 

Our multidisciplinary teams bring together expertise in:

- R&D and early development

- Quality and regulatory leadership

- Engineering and validation

- Operational excellence

- Digital transformation

 

Through this integrated approach, we support organizations at every stage of their growth and transformation.

 

Joining a Leading Innovation Ecosystem

 

Establishing our presence at Biopôle Lausanne is a natural next step in our journey. Being part of this dynamic ecosystem strengthens our proximity to innovators, entrepreneurs and decision-makers shaping the future of healthcare.

 

This move reflects our long-term commitment to supporting innovation in Switzerland and to delivering high-value expertise to our clients across Europe and beyond.

 

We look forward to contributing actively to the Biopôle community and to continuing to support life sciences organizations in addressing the challenges of tomorrow.